Skip to main content
. 2023 Jun 10;12(12):3966. doi: 10.3390/jcm12123966

Table 3.

Severity of fatigue/anxiety/depression/MoCA/functional impairment N (%).

T0 T1 T2
FAS
No fatigue 15 (9.6) 19 (16.7) 21 (27.3)
Fatigue 64 (40.8) 53 (46.5) 39 (50.7)
Severe Fatigue 78 (49.7) 42 (36.8) 17 (16.4)
GAD-7
0 minimal 36 (23.7) 32 (28.8) 42 (53.9)
1 mild 47 (30.9) 44 (39.6) 21 (26.9)
2 moderate 40 (26.3) 21 (18.9) 13 (16.7)
3 severe 29 (19.1) 14 (12.6) 2 (2.6)
PHQ-9
0 minimal 17 (11.1) 22 (20.0) 26 (33.3)
1 mild 48 (31.4) 43 (39.1) 28 (35.9)
2 moderate 43 (28.1) 25 (22.7) 17 (21.8)
3 moderately severe 33 (21.6) 13 (11.8) 7 (9.0)
4 severe 12 (7.8) 7 (6.4) 0 (0.0)
MoCA
<26 61 (38.9) 35 (31.0) 18 (25.0)
>26 96 (61.1) 78 (69.0) 54 (75.0)
PCFS
Grade 0 0 (0.0) 5 (4.4) 10 (13.0)
Grade 1 11 (7.0) 18 (15.8) 16 (20.8)
Grade 2 90 (57.0) 65 (57.0) 44 (57.1)
Grade 3 55 (34.8) 24 (21.0) 7 (9.1)
Grade 4 2 (1.3) 2 (1.8) 0 (0.0)

FAS (Fatigue Assessment Scale) reported as no fatigue (no), fatigue (fatigue) and severe fatigue (severe) according to cutoffs (<21: no, 22–34: fatigue, ≥35 severe fatigue), GAD-7 (Generalized Anxiety Disorder Scale-7) reported as minimal, mild, moderate and severe according to sum score cutoffs (<5: minimal, 5–9: mild, 10–14: moderate, ≥15 severe), PHQ-9 (Patient Health Questionnaire) reported as minimal, mild, moderate, moderately severe and severe symptoms of depression according to sum score (<5: minimal, 5–9: mild, 10–14: moderate, 15–19: moderately, ≥20: severe), MoCA (Montreal Cognitive Assessment) reported below and above cutoff for normal (26 points) (0 = below, 1 above), PCFS (Post-COVID-Functional-Status) reported as scale grade 0, 1, 2, 3 according to patient self-reporting.